Immediate Impact
59 standout
Citing Papers
Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Algirdas Šlepavičius being referenced
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Algirdas Šlepavičius | 100 | 47 | 78 | 140 | 97 | 4 | 293 | |
| A. Karapanagiotou | 95 | 2 | 39 | 178 | 91 | 11 | 309 | |
| J. Kundzins | 64 | 17 | 143 | 51 | 13 | 7 | 281 | |
| T. Giasnetsova | 57 | 2 | 27 | 140 | 78 | 8 | 258 | |
| Way Huey | 32 | 67 | 26 | 22 | 23 | 8 | 274 | |
| Paul Arnouts | 48 | 152 | 74 | 16 | 42 | 7 | 294 | |
| Alfonso Gutiérrez‐Macías | 33 | 2 | 34 | 59 | 50 | 14 | 204 | |
| D. Sfyras | 27 | 8 | 17 | 55 | 36 | 4 | 177 | |
| Patricia Salgado | 71 | 17 | 7 | 40 | 38 | 10 | 169 | |
| Christine Lawrence | 58 | 6 | 23 | 25 | 22 | 10 | 329 | |
| Silvano Cardellino | 46 | 13 | 23 | 38 | 9 | 5 | 289 |
All Works
Login with ORCID to disown or claim papers
Loading papers...